Dr Megha Rajasekhar
Dr Megha Rajasekhar is a biostatistician with the Centre for Epidemiology and Biostatistics within the School of Population and Global Health at the University of Melbourne.
Megha has worked on individual participant data meta-analyses assessing the efficacy, tolerability and haematological safety of primaquine doses in vivax malaria, and as trial statistician for several clinical trials in malaria. She has current projects studying the long-term haematological consequences of vivax malaria and changes in G6PD activity over the course of malaria infection. She also has projects on prediction modelling of immunity in malaria.
Megha is a frequent collaborator of the WorldWide Antimalarial Resistance Network (WWARN) and Menzies School of Health Research in Darwin.